Lung and heart functions of British COVID-19 patient improved

VOV.VN - A British patient suffering from the novel coronavirus (COVID-19) saw improvements in his lung functions on May 22, therefore reducing his reliance on the extracorporeal membrane oxygenation machine (ECMO) as steps are taken for the patient to gradually breath by himself, according to the Ho Chi Minh City Hospital for Tropical Diseases.

lung and heart functions of british covid-19 patient improved  hinh 0
Dr. Nguyen Van Vinh Chau, Director of the Ho Chi Minh City Hospital for Tropical Diseases, said the health condition of the 43-year-old British pilot, identified only as the Vietnam’s ‘Patient 91’, has started to show ‘hopeful signs’ with echocardiography images indicating that his heart is pulsating well.

In addition, lung ultrasound scans reveal that his left lung is no longer filled with air whilst the volume of air in both lungs has enjoyed a significant improvement in recent days.

The patient is continuing to test negative for the SARs-CoV-2 virus, after producing seven consecutive negative tests since May 7. At present, he is still on sedatives and is suffering from mild irritation while being put on an extracorporeal membrane oxygenation machine and is being treated with antibiotics and dialysis.

As of May 21, the patient's lungs have been gradually improving, therefore reducing the reliance on the ECMO therapy and being able to breath for himself.

The Ho Chi Minh City Hospital for Tropical Diseases are now preparing plans to transfer the patient to Cho Ray Hospital to undergo further treatment.

Aside from the plan to transfer the patient to Cho Ray Hospital for a lung transplant, the Ministry of Health is also considering the possibility of transferring him back to the UK.

Despite this, the transfer of the British patient will only happen when he is displaying the eligible health conditions, according to medical experts.

The patient has reportedly been experiencing cytokine storms, an overreaction of the immune system that leads to blood clots occurring in both of his lungs, resulting in the patient’s lungs having a 90% reduced capacity at some points in his treatment.


Related news